APOE ε4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein

Neuropathology and Applied Neurobiology

Volumn 29, Issue 3, 2003, Pages 231-238

  Chalmers, K ^a   Wilcock, G K ^a   Love, Seth ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

A protein; Alzheimer's disease; APOE 4; Apolipoprotein E; Cerebral amyloid angiopathy; Parenchymal A ; Phenotype

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD VESSEL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; VASCULAR AMYLOIDOSIS; BLOOD VESSEL; BRAIN; COMPARATIVE STUDY; GENETICS; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; ONSET AGE; PATHOLOGY; POLYMERASE CHAIN REACTION; TIME;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BLOOD VESSELS; BRAIN; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 0038509216     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2003.00457.x     Document Type: Article

References (33)

1. Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM. Progression of cerebral amyloid angiopathy: accumulation of amyloid-β40 in affected vessels. J Neuropathol Exp Neurol 1998: 57: 353-9
2. Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL. Gearing M. Mirra SS, Saunders AM. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 1998; 55: 326-35
3. Calhoun ME. Burgermeister P. Phinney AL. Stalder M, Tolnay M, Wiederhold KH. Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999; 96: 14088-93
4. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC Jr, Rimmler JB, Locke PA. Conneally PM, Schmader KE. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180-4
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3
6. Ellis RJ, Olichney JM, Thal LJ. Mirra SS. Morris JC, Beekly D. Heyman A. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience. Part XV. Neurology 1996: 46: 1592-6
7. Gomez-Isla T. West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ. Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease. Ann Neurol 1996: 39: 62-70
8. Greenberg S, Vonsattel J, Segal A, Chiu R. Clatworthy A. Liao A, Hyman B, Rebeck G. Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998: 50: 961-5
9. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, Pessin MS. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996: 27: 1333-7
10. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995; 38: 254-9
11. Heinonen O, Lehtovirta M, Soininen H, Helisalmi S. Mannermaa A, Sorvari H, Kosunen O, Paljarvi L. Ryynanen M, Riekkinen PJSr. Alzheimer pathology of patients carrying apolipoprotein E ε4 allele. Neurobiol Aging 1995; 16: 505-13
12. Hyman BT. West HL, Rebeck GW, Buldyrev SV. Mantegna RN, Ukleia M, Havlin S, Stanley HE. Quantitative analysis of senile plaques in Alzheimer disease, observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995; 92: 3586-90
13. Irina A, Seppo H, Arto M, Paave R, Hilkka S. β-amyloic load is not influences by the severity of cardiovascular disease in aged and demented patients. Stroke 1999; 30: 613-8
14. Kalaria RN. The role of cerebral ischemia in Aizheimer's disease. Neurobiol Aging 2000; 21: 321-30
15. Kalaria RN, Premkumar DR, Pax AB, Cohen DL, Lieberburg I. Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease. Brain Res Mol Brain Res 1996; 35: 58-68
16. Kraszpulski M, Soininen H, Helisalmi S, Alafuzoff I. The load and distribution of β-amyloid in brain tissue of patients with Alzheimer's disease. Acta Neurol Scand 2001; 103: 88-92
17. McCarron MO, Nicoll JA, Ironside JW, Love S, Alberts MJ, Bone I. Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE ε2 with putative clinical risk factors. Stroke 1999; 30: 1643-6
18. McNamara MJ, Gomez-Isla T, Hyman BT, Apolipoprotein E genotype and deposits of Aβ40 and Aβ42 in Alzheimer disease. Arch Neurol 1998; 55: 1001-4
19. Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Aizheimer's disease. Neuroscience 1995; 69: 757-61
20. Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV. High frequency of apolipoprotein E ε2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997; 41: 716-21
21. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240-5
22. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996; 47: 190-6
23. Olichney JM, Hansen LA, Hofstetter CR, Grundman M, Katzman R, Thal LJ. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995; 52: 702-8
24. Olichney JM, Hansen LA, Lee JH, Hofstetter CR, Katzman R, Thal LJ. Relationship between severe amyloid angiopathy, apolipoprotein E genotype, and vascular lesions in Alzheimer's disease. Ann N Y Acad Sci 2000; 903: 138-43
25. Pirttila T, Soininen H, Mehta PD, Heinonen O, Lehtimaki T, Bogdanovic N, Paljarvi L, Kim KS, Kosunen O, Winblad B, Riekkinen P Sr, Wisniewski HM, Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging 1997; 18: 121-7
26. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-ε4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996; 148: 2083-95
27. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649-53
28. Shinkai Y, Yoshimura M, Ito Y, Odaka A, Suzuki N, Yanagisawa K, Ihara Y. Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 1995; 38: 421-8
29. Urmoneit B, Prikulis I, Wihl G, D'Urso D, Frank R, Heeren J, Beisiegel U, Prior R. Cerebrovascular smooth muscle cells internalize Alzheimer amyloid β protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy, Laboratory Invest 1997; 77: 157-66
30. Weller RO, Massey A, Newman TA, Hutchings M, Kuo YM, Roher AE. Cerebral amyloid angiopathy: amyloid β accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998; 153: 725-33
31. Wenham PR, Price WH, Blandell G, Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158-9
32. Wyss-Coray T, Lin C, Yan FYuGQ, Rohde M, McConlogue L, Masliah E, Mucke L. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat Med 2001; 7: 612-18
33. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 1997; 389: 603-6